Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2018 Earnings

2AugConfirmed

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-6.86

-5.96

-5.05

-4.15

Details

Expected EPS

-6.44742

Actual EPS

-6.859755

Surprise EPS

-0.41

Surprise Percent

+6.4%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -6.859755 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.